ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Generate Biomedicines, a start-up founded by the venture capital firm Flagship Pioneering, will collaborate with the University of Texas MD Anderson Cancer Center to discover and develop protein therapeutics for cancer. The partnership will investigate up to five oncology targets in advanced cancers such as lung cancer. Under the terms of the agreement, the partners will share research expenses and profits from the commercialization of any resulting products.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter